Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention

Stopped early · Not applicable

Conditions studied: Cervical Cancer

In brief

The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.

Key facts

Study ID

NCT03613493

Run by

University of Miami

People needed

175

Starts

2018-07-10

Expected to finish

2018-10-01

Last updated by the study team

2019-08-02

Who can join

Age: 30 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Jamaican women, aged 30 to 65.

You may not qualify if…

• Women who report having had a hysterectomy,
• have had a history of cervical cancer,
• Women who are currently up-to-date on cervical cancer screening (have had a Pap in the last 3 years or have had a Pap smear/HPV co-test within the past 5 years),
• Adults unable to consent, children, pregnant women and prisoners.

Where it is running

• University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.